These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28795997)

  • 1. Celecoxib-induced Liver Injury: Analysis of Published Case Reports and Cases Reported to the Food and Drug Administration.
    Mukthinuthalapati PK; Fontana RJ; Vuppalanchi R; Chalasani N; Ghabril M
    J Clin Gastroenterol; 2018 Feb; 52(2):114-122. PubMed ID: 28795997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: ibuprofen-induced liver injury.
    Zoubek ME; Lucena MI; Andrade RJ; Stephens C
    Aliment Pharmacol Ther; 2020 Mar; 51(6):603-611. PubMed ID: 31984540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations.
    Bonkovsky HL; Ghabril M; Nicoletti P; Dellinger A; Fontana RJ; Barnhart H; Gu J; Daly AK; Aithal GP; Phillips EJ; Kleiner DE;
    Liver Int; 2024 Jun; 44(6):1409-1421. PubMed ID: 38451034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amoxicillin-Clavulanate-Induced Liver Injury.
    deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
    Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of idiosyncratic drug induced liver injury in Latin America: an analysis of published reports.
    Hernández N; Bessone F; Sánchez A; di Pace M; Brahm J; Zapata R; A Chirino R; Dávalos M; Méndez-Sánchez N; Arrese M; Schinoni M; Lucena MI; Andrade RJ
    Ann Hepatol; 2014; 13(2):231-9. PubMed ID: 24552865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious liver injury induced by Nimesulide: an international collaborative study.
    Bessone F; Hernandez N; Mendizabal M; Ridruejo E; Gualano G; Fassio E; Peralta M; Fainboim H; Anders M; Tanno H; Tanno F; Parana R; Medina-Caliz I; Robles-Diaz M; Alvarez-Alvarez I; Niu H; Stephens C; Colombato L; Arrese M; Reggiardo MV; Ono SK; Carrilho F; Lucena MI; Andrade RJ
    Arch Toxicol; 2021 Apr; 95(4):1475-1487. PubMed ID: 33759010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor.
    Jin Y; Regev A; Kam J; Phipps K; Smith C; Henck J; Campanale K; Hu L; Hall DG; Yang XY; Nakano M; McNearney TA; Uetrecht J; Landschulz W
    Br J Clin Pharmacol; 2018 Jan; 84(1):179-188. PubMed ID: 28865237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.
    Licata A; Calvaruso V; Cappello M; Craxì A; Almasio PL
    Dig Liver Dis; 2010 Feb; 42(2):143-8. PubMed ID: 19625223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
    Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study.
    Gulmez SE; Unal US; Lassalle R; Chartier A; Grolleau A; Moore N
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1174-1181. PubMed ID: 30112779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
    Chalasani N; Bonkovsky HL; Fontana R; Lee W; Stolz A; Talwalkar J; Reddy KR; Watkins PB; Navarro V; Barnhart H; Gu J; Serrano J;
    Gastroenterology; 2015 Jun; 148(7):1340-52.e7. PubMed ID: 25754159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware.
    Vega M; Verma M; Beswick D; Bey S; Hossack J; Merriman N; Shah A; Navarro V;
    Drug Saf; 2017 Sep; 40(9):783-787. PubMed ID: 28555362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of drug-induced liver injury in Singapore.
    Wai CT
    Singapore Med J; 2006 Feb; 47(2):116-20. PubMed ID: 16435052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal cholestatic hepatitis after a single dose of celecoxib.
    Larrey E; Patouraux S; Spreux A; Canivet CM; Piche T; Tran A; Anty R
    Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):e82-e85. PubMed ID: 30449626
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute hepatocellular and cholestatic injury in a patient taking celecoxib.
    Nachimuthu S; Volfinzon L; Gopal L
    Postgrad Med J; 2001 Aug; 77(910):548-50. PubMed ID: 11470953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions and organ damage: The liver.
    Licata A
    Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience.
    Idilman R; Bektas M; Cinar K; Toruner M; Cerit ET; Doganay B; Erden E; Bozkaya H; Bahar K; Karayalcin S; Soykan I; Palabiyikoglu M; Cetinkaya H; Yurdaydin C; Dokmeci A; Ozden A
    J Clin Gastroenterol; 2010 Jul; 44(6):e128-32. PubMed ID: 20551776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.